FLWPF (The Flowr) Research & Development: $0.75 Mil (TTM As of Sep. 2022)


What is The Flowr Research & Development?

The Flowr FLWPF -90.00% Research & Development is $0.75 Mil as of Sep. 2022.

Research & Development is the aggregate amount of research and development expenses during the year. The Flowr's Research & Development for the three months ended in Sep. 2022 was $0.20 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2022 was $0.75 Mil.


The Flowr  (OTCPK:FLWPF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


The Flowr Research & Development Related Terms


The Flowr Research & Development Historical Data

* Premium members only.

The historical data trend for The Flowr's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Flowr Research & Development Chart

The Flowr Annual Data
Trend Jun17 Jun18 Dec19 Dec20 Dec21
Research & Development
0.00 0.00 0.39 0.74 1.35

The Flowr Quarterly Data
Sep17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.31 0.11 0.13 0.20

The Flowr Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.75 Mil mean?
The Flowr (FLWPF) has a Research & Development of $0.75 Mil as of Sep. 2022. Research and development expense is the total cost for research and development activities. View historical data on The Flowr and its competitors.
Is The Flowr's Research & Development too high?
The Flowr's current Research & Development is $0.75 Mil.
How does The Flowr's Research & Development compare to ZTS and CTLT?
The Flowr's Research & Development of $0.75 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on The Flowr and its competitors. The Flowr's current Research & Development is $0.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Flowr stock overvalued right now?
The Flowr (FLWPF) has a current Research & Development of $0.75 Mil. The current Research & Development is $0.75 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For The Flowr (FLWPF), the current Research & Development is $0.75 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Flowr Business Description

Address 365 Bay Street, Suite 800, Toronto, ON, CAN, M5H 2V1
The Flowr Corp is a Toronto-headquartered cannabis company with operations in Canada and Europe. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a R&D facility that is awaiting licensing from Health Canada. From this campus, Flowr produces recreational and medicinal products. Internationally, it intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in Portugal.